Skip to main content
Clinical Trials/NCT02976168
NCT02976168
Completed
Not Applicable

Intracranial Pressure and Brain Function: Effects of Head Down Tilt Upon Brain Perfusion and Cognitive Performance

DLR German Aerospace Center1 site in 1 country13 target enrollmentMarch 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intracranial Hypertension
Sponsor
DLR German Aerospace Center
Enrollment
13
Locations
1
Primary Endpoint
Change in cognitive test battery score
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The aim of the study is to understand the relationship between intracranial pressure regulation, cerebral tissue oxygenation and cognitive functioning. More specifically, the study tests the hypothesis that head down tilt will increase intracranial pressure (not measured in this study, but demonstrated in previous studies), will induce venous congestion and facial swelling, decrease intracranial tissue oxygenation and hamper brain functioning. The objectives of the study therefore are to assess young healthy people during head-down tilt (HDT), and to assess cognitive brain functioning, cerebral tissue oxygenation (non-invasively), frontal skin thickness, cerebral perfusion and neuronal functioning via event-related potentials.

Registry
clinicaltrials.gov
Start Date
March 2016
End Date
November 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Physically and mentally healthy male test subjects that are able and declare in writing their willingness to participate in the entire study and successfully passed the psychological and medical screening
  • Aged between 18-55 years old with a Body Mass Index (BMI) of 20-28 kg/m2, weight between 65-100 kg, and a height between 158-195 cm
  • Demonstrable medical insurance and official certificate of absence of criminal record

Exclusion Criteria

  • Inability to sleep on the back
  • Drug, medication or alcohol abuse (regular consumption of more than 20-30 g alcohol/day)
  • Smoking within the past 6 months prior to study commencement
  • Migraine or other chronic head aches
  • Previous psychiatric illness
  • Subjects suffering from weak concentration
  • History of psychological or central nervous disorders
  • Hiatus hernia
  • Gastro-oesophageal reflux
  • Diabetes mellitus

Outcomes

Primary Outcomes

Change in cognitive test battery score

Time Frame: Twice at baseline, and 30 minutes and 20 hours after starting the intervention

The test battery includes sensomotoric speed, psychomotor vigilance, visual analysis of items, abstract thinking and mathematical processing

Secondary Outcomes

  • Change in total sleep time(from 22:00 until 6:00 in all nights)
  • Change in mid cerebral artery blood flow velocity(Twice at baseline, and 10 minutes and 19 hours after starting the intervention)
  • Magnetic resonance Imaging: Change in resting state functional MRI (fMRI)(Once at baseline, and 2 and 19 hours after starting the intervention)
  • Change in P-300(Twice at baseline, and 30 minutes and 20 hours after starting the intervention)
  • Magnetic resonance Imaging: Change in fMRI Response to decision task(Once at baseline, and 2 and 19 hours after starting the intervention)
  • Change in cerebral tissue oxygenation(Twice at baseline, and 10 minutes and 19 hours after starting the intervention)
  • Magnetic resonance Imaging: Change in cerebral blood flow(Once at baseline, and 2 and 19 hours after starting the intervention)
  • Change in frontal vein filling(Once at baseline, and 10 minutes and 19 hours after starting the intervention)
  • Change in jugular vein filling(Once at baseline, and 10 minutes and 19 hours after starting the intervention)
  • Change in sleep effectiveness(over the entire intervention night)

Study Sites (1)

Loading locations...

Similar Trials